Cardiff Oncology, Inc. (CRDF)

Cardiff Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	10.78	51.47	21.66	16.35	11.94	130.98
Short-Term Investments	60.17	40.28	53.17	88.92	128.88	-
Cash & Short-Term Investments	70.96	91.75	74.82	105.27	140.82	130.98
Cash Growth	17.64%	22.62%	-28.92%	-25.25%	7.51%	1184.72%
Accounts Receivable	0.53	0.77	0.29	0.77	0.54	0.32
Other Receivables	-	0.4	0.6	-	-	-
Receivables	0.53	1.17	0.89	0.77	0.54	0.32
Prepaid Expenses	2.21	2.14	1.7	5.25	4.77	2.06
Total Current Assets	73.7	95.05	77.41	111.28	146.13	133.36
Property, Plant & Equipment	1.64	2.07	2.95	3.52	3.18	0.97
Other Long-Term Assets	0.4	0.07	1.28	1.39	0.24	0.4
Total Assets	75.74	97.19	81.64	116.19	149.54	134.73
Accounts Payable	6.01	4.82	1.97	1.96	1.44	1.37
Accrued Expenses	9.94	7.9	7.78	5.18	4.11	3.46
Current Portion of Leases	0.72	0.71	0.69	0.68	0.55	0.86
Other Current Liabilities	-	-	-	-	0.46	0.43
Total Current Liabilities	16.67	13.43	10.44	7.81	6.56	6.12
Long-Term Leases	0.46	0.81	1.46	2.04	2.57	0.01
Other Long-Term Liabilities	-	-	-	-	-	0.44
Total Liabilities	17.13	14.24	11.9	9.85	9.13	6.57
Common Stock	0.01	0.01	0	0	0	0
Additional Paid-In Capital	470.14	467.09	409.34	404.83	400.5	361.82
Retained Earnings	-411.56	-384.18	-339.54	-298.1	-259.81	-231.5
Comprehensive Income & Other	0.02	0.03	-0.07	-0.4	-0.28	-2.17
Total Common Equity	58.61	82.95	69.74	106.34	140.42	128.16
Shareholders' Equity	58.61	82.95	69.74	106.34	140.42	128.16
Total Liabilities & Equity	75.74	97.19	81.64	116.19	149.54	134.73
Total Debt	1.19	1.52	2.15	2.72	3.12	0.87
Net Cash (Debt)	69.77	90.22	72.67	102.55	137.7	130.11
Net Cash Growth	19.32%	24.15%	-29.13%	-25.53%	5.83%	1436.34%
Net Cash Per Share	1.19	1.89	1.63	2.35	3.53	6.23
Filing Date Shares Outstanding	66.53	66.52	44.68	44.68	43.31	37.05
Total Common Shares Outstanding	66.53	66.52	44.68	44.68	41.96	36.78
Working Capital	57.03	81.63	66.97	103.48	139.57	127.24
Book Value Per Share	0.88	1.25	1.56	2.38	3.35	3.48
Tangible Book Value	58.61	82.95	69.74	106.34	140.42	128.16
Tangible Book Value Per Share	0.88	1.25	1.56	2.38	3.35	3.48
Machinery	2.5	2.47	2.42	2.12	1.86	1.67
Leasehold Improvements	2.57	2.57	2.57	2.56	1.96	1.96

Updated Jul 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q